EX-32 7 blph12312015ex32.htm EXHIBIT 32 Exhibit


Exhibit 32
 
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code), each of the undersigned officers of Bellerophon Therapeutics, Inc. (the “Company”), a Delaware corporation (the "Company"), does hereby certify, to such officer's knowledge, that:
 
(1)   the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
(2)   the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
Date: March 21, 2016
By:
/s/ Jonathan M. Peacock
 
 
Jonathan M. Peacock
Chief Executive Officer
(Principal Executive Officer)

 
Date: March 21, 2016
By:
/s/ Fabian Tenenbaum
 
 
Fabian Tenenbaum
Chief Financial Officer and Chief Business Officer
(Principal Financial Officer)